Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > Mari > Emblem
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Comment by spasticatedon Jul 19, 2018 1:20pm
70 Views
Post# 28339628

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Mari > Emblem

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Mari > EmblemValid points, though it's certainly easier to criticize in hindsight. I think a lot of the stock growth in this sector has been due to manipulation. I am still scratching my head about how Aurora Cannabis managed to get the valuation it did. Anyway, I think they currently have a solid plan for long term growth and that current prices are good entry points. It is unfortunate that it's come at the expense of shareholders such as myself, and perhaps I'm suffering from stockholm syndrome, but I'm still confident that I'll see my money back within the next 12 months. The sector still trades on unicorn dust, and this stock will have another pump with the rest of them.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities